Chimeron Bio Corp announced it raised $1.2 Million in an initial filing from an offering of $10 Million
Nov 30, 2022•about 3 years ago
Amount Raised
$1.2 Million
Round Type
seed
PhiladelphiaBiotechnology
Company Information
Company
Chimeron Bio
Location
601 WALNUT STREET, SUITE 715
Philadelphia, Pennsylvania, United States
About
Chimeron Bio is an early-stage biotech company focused on breakthrough treatments of cancer. Chimeron’s patented Multiplex nanoparticle and self-amplifying mRNA technology enables delivery of multiple genes to transform the complex tumor micro-environment with a unique “All-in-One” treatment approach. Chimeron is developing a high-impact pipeline for the creation and delivery therapeutics with the potential for meaningful patient results.
Philadelphia